Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
作者信息
Gore M E, Riches P, MacLennan K, O'Brien M, Moore J, Dadian G, Lorentzos A, Garth R, Moskovic E, Archer D
机构信息
Biological Therapies Group, Royal Marsden Hospital, London, UK.
出版信息
Br J Cancer. 1992 Aug;66(2):405-7. doi: 10.1038/bjc.1992.278.
Abstract
摘要
相似文献
1
Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌动脉内注射白细胞介素-2的I期研究。
Br J Cancer. 1992 Aug;66(2):405-7. doi: 10.1038/bjc.1992.278.
2
Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌局部定向白细胞介素-2治疗引起的外周血免疫变化。
Eur J Cancer B Oral Oncol. 1993 Jan;29B(1):29-34. doi: 10.1016/0964-1955(93)90007-2.
3
The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.鳞状细胞癌患者动脉内输注白细胞介素-2后肿瘤浸润淋巴细胞和肿瘤细胞的表型变化。
J Pathol. 1995 Jun;176(2):167-73. doi: 10.1002/path.1711760210.
4
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.通过低剂量而非高剂量的重组白细胞介素2经淋巴管周围注射，可使复发性头颈部鳞状细胞癌暂时消退。
Br J Cancer. 1994 Mar;69(3):572-6. doi: 10.1038/bjc.1994.104.
5
[A phase 2 study of recombinant interleukin 2 (S-6820) for head and neck cancer].重组白细胞介素2（S-6820）治疗头颈癌的2期研究
Gan No Rinsho. 1990 Feb;36(2):111-20.
6
Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial.头颈部晚期鳞状细胞癌患者瘤周及瘤内注射白细胞介素-2疗效的Ib期试验：一项东部肿瘤协作组试验
J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):134-9. doi: 10.1097/00002371-199402000-00007.
7
[The effect of IL-2 injection around the metastatic cervical lymphnode].[白细胞介素-2注射于转移性颈部淋巴结周围的效果]
Nihon Gan Chiryo Gakkai Shi. 1990 Jun 20;25(6):1119-22.
8
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically.经鼓阶周围注射低剂量白细胞介素-2治疗复发性头颈部鳞状细胞癌。
Cancer. 1988 Dec 15;62(12):2482-5. doi: 10.1002/1097-0142(19881215)62:12<2482::aid-cncr2820621205>3.0.co;2-9.
9
Perilesional interleukin-2 in the VX-2 carcinoma in rabbits: a preliminary investigation.兔VX-2癌瘤周围白细胞介素-2的初步研究
Otolaryngol Head Neck Surg. 1995 Mar;112(3):430-6. doi: 10.1016/S0194-59989570279-2.
10
Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.逆行动脉内化疗联合每日同步质子束治疗复发性口腔鳞状细胞癌：46例治疗结果分析
Head Neck. 2016 Aug;38(8):1145-51. doi: 10.1002/hed.24421. Epub 2016 Mar 28.
引用本文的文献
1
Head and neck chemotherapy.
AJNR Am J Neuroradiol. 2001 Sep;22(8 Suppl):S16-7.
2
Interferons and other cytokines in head and neck cancer.头颈部癌症中的干扰素及其他细胞因子。
Med Oncol. 1995 Mar;12(1):23-33. doi: 10.1007/BF01571405.
3
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.通过低剂量而非高剂量的重组白细胞介素2经淋巴管周围注射，可使复发性头颈部鳞状细胞癌暂时消退。
Br J Cancer. 1994 Mar;69(3):572-6. doi: 10.1038/bjc.1994.104.
4
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.白细胞介素-2。其药理学特性及在癌症患者中的治疗应用综述。
Drugs. 1993 Sep;46(3):446-514. doi: 10.2165/00003495-199346030-00009.
本文引用的文献
1
Reporting results of cancer treatment.癌症治疗结果报告。
Cancer. 1981 Jan 1;47(1):207-14. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
2
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.淋巴因子激活的杀伤细胞现象。白细胞介素2激活的自体人外周血淋巴细胞对天然杀伤抗性新鲜实体瘤细胞的杀伤作用。
J Exp Med. 1982 Jun 1;155(6):1823-41. doi: 10.1084/jem.155.6.1823.
3
Interleukin-2 augments natural killer cell activity.白细胞介素-2增强自然杀伤细胞的活性。
Nature. 1981 May 28;291(5813):335-8. doi: 10.1038/291335a0.
4
Expression of interleukin 2 receptors on activated human B cells.白细胞介素2受体在活化的人B淋巴细胞上的表达
J Exp Med. 1984 Nov 1;160(5):1450-66. doi: 10.1084/jem.160.5.1450.
5
6
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes.重组白细胞介素-2直接增强人单核细胞的细胞毒性。
Nature. 1987;325(6101):262-5. doi: 10.1038/325262a0.
7
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.大剂量白细胞介素-2治疗652例癌症患者的经验。
Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5. doi: 10.1097/00000658-198910000-00008.
8
Effects of cytokines on vascular endothelium: their role in vascular and immune injury.细胞因子对血管内皮的影响：它们在血管和免疫损伤中的作用。
Kidney Int. 1989 Apr;35(4):969-75. doi: 10.1038/ki.1989.80.
9
Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases.肝转移患者脾动脉与肝动脉输注白细胞介素-2的比较
J Clin Oncol. 1990 Feb;8(2):319-24. doi: 10.1200/JCO.1990.8.2.319.
10
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy.一项前瞻性随机试验，评估预防性抗生素在接受免疫治疗的患者中预防三腔导管相关败血症的效果。
J Clin Oncol. 1990 Jan;8(1):161-9. doi: 10.1200/JCO.1990.8.1.161.
Zotero 插件